NCT03501862

Brief Summary

People with psychosis demonstrated a tendency to use maladaptive cognitive emotion regulation strategies as compared with healthy control groups. The present study is the first randomized controlled trial of group mindfulness-based intervention for psychosis. Half group will join the mindfulness-based cognitive intervention while another half will participate in psychoeducation to examine whether mindfulness will have a positive impact on emotion regulation and distress.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2017

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 9, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 18, 2018

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2021

Completed
Last Updated

September 27, 2021

Status Verified

September 1, 2021

Enrollment Period

4.5 years

First QC Date

March 9, 2018

Last Update Submit

September 20, 2021

Conditions

Keywords

MindfulnessCognitive therapy

Outcome Measures

Primary Outcomes (1)

  • The Depression Anxiety Stress Scale - short form (DASS-21)

    ). It is chosen as the primary outcome measurement because scales of anxiety and depression possess the capacity to differentiate from the related state of tension and stress linking with environmental demands and emotional and physical disturbance. It is a 21-item instrument that measures over the past week symptoms of depression, anxiety and stress rated by 4-point severity or frequency scale. The scale is from 0 (did not apply to me at all) to 3 (applied to me very much or most of the time).

    Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention

Secondary Outcomes (7)

  • The Emotion Regulation Questionnaire (ERQ)

    Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention

  • The WHOQOL-100

    Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention

  • Positive and Negative Syndrome Scale (PANSS)

    Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention

  • Acceptance and Action Scale (AAQII)

    Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention

  • Five Facet Mindfulness Questionnaire (FFMQ)

    Changes will be assessed pre-study; at one week, 3-month and 6-month post-intervention

  • +2 more secondary outcomes

Study Arms (2)

Mindfulness-based intervention

EXPERIMENTAL

Intervention: a twelve 1.5 weekly program on mindfulness-based cognitive therapy (psychosis)

Behavioral: Mindfulness-based cognitive therapy (psychosis)

Psychoeducation

ACTIVE COMPARATOR

Intervention: a twelve 1.5 hours weekly program on psychoeducation (psychosis)

Behavioral: Psychoeducation (psychosis)

Interventions

A small group intervention is based on a structured and validated protocol that will include mindfulness practice, cognitive skills

Mindfulness-based intervention

A small group intervention will be focusing on understanding of psychosis, treatment, relapse prevention and useful information and resources.

Psychoeducation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be Chinese residents and aged above 18
  • Have a primary diagnosis of psychosis (non-affective) and/or other psychotic disorders met the Diagnostic and Statistical Manual DSM-5
  • Have been diagnosed equivalent to or less than 5 years
  • Mentally stable as assessed by the researcher and a psychiatrist to comprehend the education and training provided (a pre-recruitment briefing session for potential participants will be conducted to verify their ability to follow instructions and understanding in participation, and case files will be reviewed to ensure a stable medication regime for at least 6 months) in order to ensure their ability to make a valid consent
  • Able to read and understand Chinese

You may not qualify if:

  • Have recently participated in (less than 3 months) or are receiving other structured psycho-education and/or psychotherapies
  • Have comorbidities (a) developmental impairment (b) learning disability, (c) personality disorders, and/or (d) any clinically significant medical diseases (by case-file review).
  • Have organic psychosis or a primary drug or alcohol addiction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Fourth People's Hospital

Chengdu, China

Location

The Society of Rehabilitation and Crime Prevention

Hong Kong, Hong Kong

Location

MeSH Terms

Interventions

Mindfulness-Based Cognitive Therapy

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Thanos Karatzias

    Edinburgh Napier University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Assignment to the study groups will be made independently of staff involved in the recruitment and management of participants in the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants referred to the study will be assessed at a screening examination to ensure eligibility and obtain written consent by a research assistant. Eligible participants will undertake a further interview on outcome measures prior to randomization within 3 weeks the commencement of intervention. Eligible participants will be randomly assigned to receive Mindfulness-based Cognitive Therapy for Psychosis (MBCTp) plus TAU or TAU plus Psychoeducation for Psychosis (PEp). Simple randomization will be used to ensure that participants will have equal opportunity to be included into the study (Altaman and Bland, 1999).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Clinical Associate

Study Record Dates

First Submitted

March 9, 2018

First Posted

April 18, 2018

Study Start

January 15, 2017

Primary Completion

July 31, 2021

Study Completion

July 31, 2021

Last Updated

September 27, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication

Shared Documents
SAP, CSR
Time Frame
3-months after publication
Access Criteria
Request by sending email

Locations